Risk Factors for Weight Gain Following Switch to Integrase Inhibitor–Based Antiretroviral Therapy

BACKGROUND: Treatment initiation with integrase strand transfer inhibitors (INSTIs) has been associated with excess weight gain. Whether similar gains are seen after switch to INSTIs among virologically suppressed persons is less clear. We assessed pre/post-INSTI weight changes from AIDS Clinical Tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Lake, Jordan E, Wu, Kunling, Bares, Sara H, Debroy, Paula, Godfrey, Catherine, Koethe, John R, McComsey, Grace A, Palella, Frank J, Tassiopoulos, Katherine, Erlandson, Kristine M
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Online Only Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7713693/
https://ncbi.nlm.nih.gov/pubmed/32099991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa177
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados